Support safe administration of LSD dosing sessions

The manuals converge on the need for careful, protocol-bound support during LSD or other psychedelic dosing sessions in a clinical research setting. Across the extracts, session work is framed as structured oversight, with attention to participant welfare, safety monitoring, and therapeutic support during drug administration. They also share an emphasis on consistency and controlled conditions, whether that means a calm environment, repeated monitoring, or adherence to dosing-session procedures. The sources differ in how much operational detail they provide. The mescaline study describes prolonged session oversight, including continuous responsibility across acute and subacute phases, no time alone during the first 16 hours, investigator availability for up to 30 hours, and a standardised schedule with meals and next-day discharge planning. By contrast, the LSD psychotherapy manual focuses more narrowly on delivering support during full-dose and low-dose or active-placebo conditions, keeping sessions consistent when spaced 2 to 3 weeks apart, and coordinating with protocolised medication administration rather than changing dose conditions independently. The protocol summary for advanced-stage disease is more general again, framing the competency as safety monitoring and observing for adverse effects in a therapeutic research environment. So, while all three sources align on safety and structured support, they differ in whether the emphasis is on prolonged session supervision, dose-condition fidelity, or broad safety evaluation.